What is the address of DOCTEUR SCI. JULIE CREVECOEUR?

The registered office of DOCTEUR SCI. JULIE CREVECOEUR is located at Rue Sainte-Marie 16 box 12, 4000 Liège.

Is DOCTEUR SCI. JULIE CREVECOEUR still active?

Yes. According to the CBE (3 October 2026) DOCTEUR SCI. JULIE CREVECOEUR is active, legal situation “Normale toestand”, started on 12 January 2021.

Is DOCTEUR SCI. JULIE CREVECOEUR registered on Peppol?

No, DOCTEUR SCI. JULIE CREVECOEUR is currently not registered on the Peppol network.

What is the enterprise number of DOCTEUR SCI. JULIE CREVECOEUR?

The enterprise number of DOCTEUR SCI. JULIE CREVECOEUR is BE0761477318.

When was DOCTEUR SCI. JULIE CREVECOEUR founded?

DOCTEUR SCI. JULIE CREVECOEUR was founded on 12 January 2021.

Who are the directors of DOCTEUR SCI. JULIE CREVECOEUR?

According to the 2025 annual accounts, the directors of DOCTEUR SCI. JULIE CREVECOEUR are: Julie Crevecoeur.

Is DOCTEUR SCI. JULIE CREVECOEUR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 January 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOCTEUR SCI. JULIE CREVECOEUR make in 2025?

DOCTEUR SCI. JULIE CREVECOEUR posted a profit after taxes of € 68,870 in financial year 2025.

What is the revenue of DOCTEUR SCI. JULIE CREVECOEUR?

As a small company, DOCTEUR SCI. JULIE CREVECOEUR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 102,701.

DOCTEUR SCI. JULIE CREVECOEUR (Private Limited) - Liège

Dossier DOCTEUR SCI. JULIE CREVECOEUR, printed on 3 October 2026 from databakkes.be/en/0761477318/docteur-sci-julie-crevecoeur. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOCTEUR SCI. JULIE CREVECOEUR from Liège, company number BE0761477318, closed financial year 2025 with a result of € 68,870 after tax. For that financial year DOCTEUR SCI. JULIE CREVECOEUR recorded a gross margin of € 102,701 and equity of € 3,366. Compared with financial year 2024, the result moved from € 64,293 to € 68,870. Profitable, and profit is growing. The buffer shrank hard: equity is 87 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 27, 2026.

What it is worth Shrank hard

€ 3,366

▼ 87% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 68,870

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 73,596

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 90,500 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,482

▼ 75% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 3,214

▼ 70% vs 2024

Loans from banks and other lenders, long and short.

Taxes

€ 81

▼ 95% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 29,881 Gross margin 2022: € 29,881 First fiscal year in the series	€ 43,807 Gross margin 2023: € 43,807 ▲ 47% vs 2022 (€ 29,881) Favourable step	€ 96,350 Gross margin 2024: € 96,350 ▲ 120% vs 2023 (€ 43,807) Favourable step	€ 102,701 Gross margin 2025: € 102,701 ▲ 7% vs 2024 (€ 96,350) Favourable step	▲ 7%
Profit after taxes	€ 16,463 Profit after taxes 2022: € 16,463 First fiscal year in the series	€ 27,384 Profit after taxes 2023: € 27,384 ▲ 66% vs 2022 (€ 16,463) Favourable step	€ 64,293 Profit after taxes 2024: € 64,293 ▲ 135% vs 2023 (€ 27,384) Favourable step	€ 68,870 Profit after taxes 2025: € 68,870 ▲ 7% vs 2024 (€ 64,293) Favourable step	▲ 7%
Equity	€ 33,319 Equity 2022: € 33,319 First fiscal year in the series	€ 60,703 Equity 2023: € 60,703 ▲ 82% vs 2022 (€ 33,319) Favourable step	€ 24,996 Equity 2024: € 24,996 ▼ 59% vs 2023 (€ 60,703) Unfavourable step	€ 3,366 Equity 2025: € 3,366 ▼ 87% vs 2024 (€ 24,996) Unfavourable step	▼ 87%
Total debts	€ 35,849 Total debts 2022: € 35,849 First fiscal year in the series	€ 28,240 Total debts 2023: € 28,240 ▼ 21% vs 2022 (€ 35,849) Favourable step	€ 59,039 Total debts 2024: € 59,039 ▲ 109% vs 2023 (€ 28,240) Unfavourable step	€ 87,131 Total debts 2025: € 87,131 ▲ 48% vs 2024 (€ 59,039) Unfavourable step	▲ 48%
Cash	€ 35,217 Cash 2022: € 35,217 First fiscal year in the series	€ 70,903 Cash 2023: € 70,903 ▲ 101% vs 2022 (€ 35,217) Favourable step	€ 72,682 Cash 2024: € 72,682 ▲ 3% vs 2023 (€ 70,903) Favourable step	€ 73,596 Cash 2025: € 73,596 ▲ 1% vs 2024 (€ 72,682) Favourable step	▲ 1%
Retained profit	€ 30,319 Retained profit 2022: € 30,319 First fiscal year in the series	€ 57,703 Retained profit 2023: € 57,703 ▲ 90% vs 2022 (€ 30,319) Favourable step	€ 21,996 Retained profit 2024: € 21,996 ▼ 62% vs 2023 (€ 57,703) Unfavourable step	€ 366 Retained profit 2025: € 366 ▼ 98% vs 2024 (€ 21,996) Unfavourable step	▼ 98%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2024: € 100,000 Unchanged (€ 0) Unchanged	€ 90,500 Dividend 2025: € 90,500 ▼ 9% vs 2024 (€ 100,000) Unchanged	▼ 9%
Bank debt	€ 25,911 Bank debt 2022: € 25,911 First fiscal year in the series	€ 18,432 Bank debt 2023: € 18,432 ▼ 29% vs 2022 (€ 25,911) Favourable step	€ 10,867 Bank debt 2024: € 10,867 ▼ 41% vs 2023 (€ 18,432) Favourable step	€ 3,214 Bank debt 2025: € 3,214 ▼ 70% vs 2024 (€ 10,867) Favourable step	▼ 70%
Balance sheet total	€ 69,168 Balance sheet total 2022: € 69,168 First fiscal year in the series	€ 88,943 Balance sheet total 2023: € 88,943 ▲ 29% vs 2022 (€ 69,168) Unchanged	€ 84,035 Balance sheet total 2024: € 84,035 ▼ 6% vs 2023 (€ 88,943) Unchanged	€ 90,497 Balance sheet total 2025: € 90,497 ▲ 8% vs 2024 (€ 84,035) Unchanged	▲ 8%

Key figures of DOCTEUR SCI. JULIE CREVECOEUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOCTEUR SCI. JULIE CREVECOEUR?

What happened at DOCTEUR SCI. JULIE CREVECOEUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 27, 2026 New annual accounts for financial year 2025: profit of € 68,870 (▲ 7% vs 2024). Source: NBB ↗
Jan 12, 2021 New establishment in Liège. KBO
2021 Julie Crevecoeur became a director. NBB
Jan 12, 2021 Start of the company according to the CBE. KBO

In short

From € 16,463 profit in 2022 to € 68,870 profit in 2025.

Paid € 61,064 in corporate taxes since 2022.

Best year ever: 2025, with € 68,870 profit.

Paid out € 190,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOCTEUR SCI. JULIE CREVECOEUR? We notify you, reason included.

Follow DOCTEUR SCI. JULIE CREVECOEUR

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Julie Crevecoeur

DOCTEUR SCI. JULIE CREVECOEUR

Behind DOCTEUR SCI. JULIE CREVECOEUR is Julie Crevecoeur.

See the full network in the app

Directors

According to the 2025 annual accounts

Julie Crevecoeur

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Sainte-Marie 16 box 12

4000 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0761.477.318
VAT number: BE 0761.477.318
Registered office: Rue Sainte-Marie 16 bus 12, 4000 Liège
Names & denominations: DOCTEUR SCI. JULIE CREVECOEUR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 January 2021
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗